We are live on ! Find out more
RVPH

REVIVA PHARMA HLDGS INC
RVPH

Delisted

RVPH was delisted on the 13th of May, 2026.

Back to rankings

42 hedge funds and large institutions have $3.52M invested in REVIVA PHARMA HLDGS INC in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,404% more call options, than puts

Call options by funds: $576K | Put options by funds: $23K

0.8% less ownership

Funds ownership: 1.49% → 0.69% (-0.8%)

9% less funds holding

Funds holding: 46 → 42 (-4)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

35% less capital invested

Capital invested by funds: $5.44M → $3.52M (-$1.93M)

Holders
42
Holders Change
-4
Holders Change %
-8.7%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
10
Closed
10
Calls
$576K
Puts
$23K
Net Calls
+$553K
Net Calls Change
-$1.68M

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$182K
2
Jane Street
Jane Street
New York
+$97K
3
Millennium Management
Millennium Management
New York
+$94.8K
4
Renaissance Technologies
Renaissance Technologies
New York
+$92K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$50.6K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$1.03M
2
HCM
Heights Capital Management
California
-$697K
3
6CM
683 Capital Management
New York
-$381K
4
DP
Diadema Partners
New Jersey
-$97.1K
5
SM
Sabby Management
Florida
-$72.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$7K -$484 -57 -5%
Raymond James Financial
27
Raymond James Financial
Florida
$5.53K – – –
NWM
28
NRI Wealth Management
California
$4.56K – – –
TWC
29
TD Waterhouse Canada
Ontario, Canada
$4.53K – – –
SG Americas Securities
30
SG Americas Securities
New York
$4K +$4.91K +578 New
DWM
31
Drive Wealth Management
Utah
$3.69K -$4.25K -500 -50%
SA
32
Sanctuary Advisors
Indiana
$3.69K -$425 -50 -9%
IAS
33
Insigneo Advisory Services
Florida
$3.69K – – –
Northwestern Mutual Wealth Management
34
Northwestern Mutual Wealth Management
Wisconsin
$3.43K – – –
Wells Fargo
35
Wells Fargo
California
$2.58K +$1.7K +200 +133%
SS
36
SBI Securities
Japan
$1.84K -$8 -1 -0.4%
Morgan Stanley
37
Morgan Stanley
New York
$1.52K – – –
IA
38
IFP Advisors
Florida
$1.47K – – –
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$1K – – –
AWM
40
Activest Wealth Management
Florida
$369 – – –
Bank of America
41
Bank of America
North Carolina
$198 +$42 +5 +23%
TCM
42
Tradewinds Capital Management
Washington
$93 – – –
AC
43
Armistice Capital
New York
– -$1.03M -134,600 Closed
HCM
44
Heights Capital Management
California
– -$697K -91,495 Closed
6CM
45
683 Capital Management
New York
– -$381K -50,000 Closed
SM
46
Sabby Management
Florida
– -$72.2K -8,496 Closed
APM
47
Avidity Partners Management
Texas
– -$52.6K -6,900 Closed
WAM
48
Warberg Asset Management
Illinois
– -$18.1K -2,375 Closed
Charles Schwab
49
Charles Schwab
California
– -$5.72K -750 Closed
Jones Financial Companies
50
Jones Financial Companies
Missouri
– -$283 -42 Closed
1
2
3

RVPH Hedge Fund Activity: Q3 2025 in Review

42 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q3 2025, worth a combined $3.52M — down 35% from $5.44M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of RVPH and 7 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Susquehanna International Group, adding an estimated $182K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.03M sold.

  • 42 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q3 2025, down from 46 in Q2 2025.
  • Funds reported $3.52M of REVIVA PHARMA HLDGS INC stock for Q3 2025, down 35% quarter-over-quarter.
  • 7 funds opened new REVIVA PHARMA HLDGS INC positions in Q3 2025 and 10 closed out, a net change of -3 holders.
  • The largest REVIVA PHARMA HLDGS INC buyer in Q3 2025 was Susquehanna International Group, an estimated $182K added.
  • The largest REVIVA PHARMA HLDGS INC seller in Q3 2025 was Armistice Capital, an estimated $1.03M sold.

Based on aggregated 13F filings for Q3 2025.